Beijing's hold over rare metals, China cuts mortgage rate benchmark: SCMP daily highlights
Catch up on some of SCMP's biggest China stories of the day. If you would like to see more of our reporting, please consider
subscribing
Beijing is still tightening its grip over supplies of rare earths and other key minerals despite the tariff truce, allowing it to cut off US access at will.
China slashed a key reference rate for mortgage loans by 10 basis points on Tuesday amid efforts to stabilise the property market, but analysts said the moderate cut was still insufficient to revive a sector mired in a downturn.
A screen shows trading indexes at the New York Stock Exchange (NYSE) in New York City, US, May 19, 2025. Photo: Reuters
China attracted a significant net capital inflow into its bond and equities markets in April despite US President Donald Trump's tariff war and can expect more foreign investment in Chinese assets, analysts said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Standard
19 minutes ago
- The Standard
HK stocks rise with regional shares as Sino-US talks expected soon
The Hang Seng Index rose 168 points, or 0.72 percent, to 23,680 at the midday break. SING TAO
South China Morning Post
an hour ago
- South China Morning Post
China's Ping An raises US$1.5 billion from convertible bonds to fund growth
Ping An Insurance (Group), China's largest insurer by market capitalisation, plans to raise HK$11.77 billion (US$1.5 billion) via convertible bonds to fund the growth of its core business and support its healthcare initiatives. The zero-coupon note due in 2030 is the biggest convertible bond denominated in US dollars or Hong Kong dollars by a Chinese company this year, according to Bloomberg data. It follows a US$690 million convertible senior note by video-sharing services provider Bilibili and a US$550 million convertible bond by data centre operator GDS Holdings in May. 'The company intends to apply the net proceeds from the issue of the bonds to further develop the group's core business and strengthen the group's capital position, support the group's new strategic initiatives in the healthcare and elderly-care sectors and for general corporate purposes,' Ping An said in a filing to the Hong Kong stock exchange on Wednesday. Ping An's bonds will be listed on the Frankfurt Stock Exchange. Photo: Reuters The bonds, which will be listed on the Frankfurt Stock Exchange, can be redeemed at par value on June 11, 2028.
South China Morning Post
2 hours ago
- South China Morning Post
How 3 Hong Kong health and biotech start-ups aim to help improve the lives of millions
What makes a business idea stand out? The answer to this perennial question may be found in the 2025 EQT Impact Challenge – a start-up pitch competition in Hong Kong which was previously held in Japan, South Korea and Singapore. One feature of the current edition has been the impressive quality of submissions by many early-stage companies: start-ups operating at the intersection of cutting-edge science and scalable impact. Some of them benefit from the backing of university departments, research institutes, accelerators, incubators, or prominent mentors. Others have already established preliminary links with major companies to help them take the next crucial steps. However, all are committed to steering breakthrough innovations from the laboratory to the commercial market. In many cases, the projects they are working on have the potential to improve the lives of millions of people in the long term. Three excellent examples related to health and biotechnology have made it through to the top five of this year's competition, which is organised by EQT, one of the world's largest investment firms, with its philanthropic arm, EQT Foundation, providing the winning start-up capital to fuel growth, and access to a global network of industry partners and potential investors. The event is being held in partnership with the South China Morning Post. The next stage will involve public voting, with the four that gain the most votes reaching the grand finale. These remaining contenders will have the opportunity to raise their profile, expand their contacts with industry experts and interested investors, and further benefit from the support offered by Hong Kong's dynamic start-up ecosystem. Allegrow Biotech, based at Hong Kong Science Park in Pak Shek Kok, in the New Territories, was set up in 2022 as a spin-off start-up at the biomaterials lab at Hong Kong University of Science and Technology (HKUST).
